相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibitor treatment of peripheral mononuclear cells from Parkinson's disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarker
G. Perera et al.
SCIENTIFIC REPORTS (2016)
F-box protein 7 mutations promote protein aggregation in mitochondria and inhibit mitophagy
Zhi Dong Zhou et al.
HUMAN MOLECULAR GENETICS (2015)
Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21WAF1/CIP1 expression
Dong Hwan Ho et al.
MOLECULAR BRAIN (2015)
Higher Frequency of Certain Cancers in LRRK2 G2019S Mutation Carriers With Parkinson Disease A Pooled Analysis
Ilir Agalliu et al.
JAMA NEUROLOGY (2015)
DNA Damage and Its Links to Neurodegeneration
Ram Madabhushi et al.
NEURON (2014)
Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7
Ruth Chia et al.
NATURE COMMUNICATIONS (2014)
The ATM protein kinase: regulating the cellular response to genotoxic stress, and more
Yosef Shiloh et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
Shared Predispositions of Parkinsonism and Cancer A Population-Based Pedigree-Linked Study
Seth A. Kareus et al.
ARCHIVES OF NEUROLOGY (2012)
Re-examination of the dimerization state of leucine-rich repeat kinase 2: predominance of the monomeric form
Genta Ito et al.
BIOCHEMICAL JOURNAL (2012)
Phosphorylation of LRRK2: from kinase to substrate
Evy Lobbestael et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2
Renee Vancraenenbroeck et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2012)
EGFR-dependent phosphorylation of leucine-rich repeat kinase LRRK1 is important for proper endosomal trafficking of EGFR
Kouki Ishikawa et al.
MOLECULAR BIOLOGY OF THE CELL (2012)
Role of p53 in Neurodegenerative Diseases
J. Robert Chang et al.
NEURODEGENERATIVE DISEASES (2012)
Parkinson disease, cancer, and LRRK2 Causation or association?
Oliver Bandmann et al.
NEUROLOGY (2012)
The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers
R. Inzelberg et al.
NEUROLOGY (2012)
The IkappaB Kinase Family Phosphorylates the Parkinson's Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling
Nicolas Dzamko et al.
PLOS ONE (2012)
Chemoproteomics-Based Design of Potent LRRK2-Selective Lead Compounds That Attenuate Parkinson's Disease-Related Toxicity in Human Neurons
Nigel Ramsden et al.
ACS CHEMICAL BIOLOGY (2011)
Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System Atrophy
Yu Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
A positive role for c-Abl in Atm and Atr activation in DNA damage response
X. Wang et al.
CELL DEATH AND DIFFERENTIATION (2011)
Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2
Xianming Deng et al.
NATURE CHEMICAL BIOLOGY (2011)
Meta-analysis of the relationship between Parkinson disease and melanoma
Rui Liu et al.
NEUROLOGY (2011)
P53 and aging: A fresh look at an old paradigm
Masha V. Poyurovsky et al.
AGING-US (2010)
Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
Nicolas Dzamko et al.
BIOCHEMICAL JOURNAL (2010)
14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
R. Jeremy Nichols et al.
BIOCHEMICAL JOURNAL (2010)
New Therapeutic Strategy for Parkinson's and Alzheimer's Disease
E. Esposito et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Phosphopeptide Analysis Reveals Two Discrete Clusters of Phosphorylation in the N-Terminus and the Roc Domain of the Parkinson-Disease Associated Protein Kinase LRRK2
Christian Johannes Gloeckner et al.
JOURNAL OF PROTEOME RESEARCH (2010)
A Cytoplasmic ATM-TRAF6-cIAP1 Module Links Nuclear DNA Damage Signaling to Ubiquitin-Mediated NF-κB Activation
Michael Hinz et al.
MOLECULAR CELL (2010)
Modes of p53 Regulation
Jan-Philipp Kruse et al.
CELL (2009)
ATM activates p53 by regulating MDM2 oligomerization and E3 processivity
Qian Cheng et al.
EMBO JOURNAL (2009)
Leucine-Rich Repeat Kinase 2 (LRRK2): A Key Player in the Pathogenesis of Parkinson's Disease
Payal N. Gandhi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
The DNA-damage response in human biology and disease
Stephen P. Jackson et al.
NATURE (2009)
Family history of melanoma and Parkinson disease risk
X. Gao et al.
NEUROLOGY (2009)
MOLECULAR ORIGINS OF CANCER DNA Damage, Aging, and Cancer
Jan H. J. Hoeijmakers
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The involvement of DNA-damage and -repair defects in neurological dysfunction
Avanti Kulkarni et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
The Parkinson disease-associated leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation
Elisa Greggio et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
ARE PARKINSON DISEASE PATIENTS PROTECTED FROM SOME BUT NOT ALL CANCERS?
Audrey J. Strongosky et al.
NEUROLOGY (2008)
Hepatitis C virus NS3/4A protein interacts with ATM, impairs DNA repair and enhances sensitivity to ionizing radiation
Chao-Kuen Lai et al.
VIROLOGY (2008)
Activation and regulation of ATM kinase activity in response to DNA double-strand breaks
J-H Lee et al.
ONCOGENE (2007)
Defective DNA repair and Neurodegenerative disease
Ulrich Rass et al.
CELL (2007)
Apoptotic mechanisms in mutant LRRK2-mediated cell death
Ciro Iaccarino et al.
HUMAN MOLECULAR GENETICS (2007)
Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity
Andrew B. West et al.
HUMAN MOLECULAR GENETICS (2007)
Met acts on Mdm2 via mTOR to signal cell survival during development
Anice Moumen et al.
DEVELOPMENT (2007)
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Wanli W. Smith et al.
NATURE NEUROSCIENCE (2006)
The ATM-mediated DNA-damage response: taking shape
Yosef Shiloh
TRENDS IN BIOCHEMICAL SCIENCES (2006)
LRRK2 in Parkinson's disease: protein domains and functional insights
Ignacio F. Mata et al.
TRENDS IN NEUROSCIENCES (2006)
Induction and quantification of γ-H2AX foci following low and high LET-irradiation
EL Leatherbarrow et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2006)
ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks
A Jazayeri et al.
NATURE CELL BIOLOGY (2006)
Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration
WW Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
AB West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Understanding the odd science of aging
TBL Kirkwood
CELL (2005)
Focus formation of DNA repair proteins in normal and repair-deficient cells irradiated with high-LET ions
KH Karlsson et al.
RADIATION RESEARCH (2004)
Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species
EU Kurz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Gene regulation and DNA damage in the ageing human brain
T Lu et al.
NATURE (2004)
Histone deacetylases (HDACs): characterization of the classical HDAC family
AJM De Ruijter et al.
BIOCHEMICAL JOURNAL (2003)
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
CJ Bakkenist et al.
NATURE (2003)
Ataxia telangiectasia mutated is essential during adult neurogenesis
DR Allen et al.
GENES & DEVELOPMENT (2001)
Cellular responses to DNA damage
CJ Norbury et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
The many substrates and functions of ATM
MB Kastan et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2000)
ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation
C Barlow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
